Pro- and antiangiogenic therapies: current status and clinical implications

被引:62
作者
Rust, Ruslan [1 ,2 ]
Gantner, Christina [3 ]
Schwab, Martin E. [1 ,2 ]
机构
[1] Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland
[2] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland
[3] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland
关键词
vascularization; vascular repair; stroke; retinopathy; cancer; ENDOTHELIAL GROWTH-FACTOR; METASTATIC COLORECTAL-CANCER; CHRONIC MYOCARDIAL-ISCHEMIA; MESENCHYMAL STEM-CELLS; ANTI-VEGF THERAPY; VASCULAR-PERMEABILITY; PROGENITOR CELLS; IN-VITRO; INTRAVITREAL INJECTION; PROMOTES ANGIOGENESIS;
D O I
10.1096/fj.201800640RR
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Blood vessels nurture every part of the human body. Consequently, abnormalities in the vasculature are closely associated with a variety of diseases, including cerebral stroke, heart disease, retinopathy, and cancer. Pro- or antiangiogenic therapies can influence these diseases by regulating the growth of new blood vessels from a pre-existing vascular network or dampening excessive blood growth. However, clinical translation of these approaches is slow and challenging. In this review, we discuss recent preclinical approaches to regulate angiogenesis and their potential and risks in a clinical setting.Rust, R., Gantner, C., Schwab, M. E. Pro- and antiangiogenic therapies: current status and clinical implications.
引用
收藏
页码:34 / 48
页数:15
相关论文
共 128 条
[21]   FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study [J].
Cremolini, Chiara ;
Loupakis, Fotios ;
Antoniotti, Carlotta ;
Lupi, Cristiana ;
Sensi, Elisa ;
Lonardi, Sara ;
Mezi, Silvia ;
Tomasello, Gianluca ;
Ronzoni, Monica ;
Zaniboni, Alberto ;
Tonini, Giuseppe ;
Carlomagno, Chiara ;
Allegrini, Giacomo ;
Chiara, Silvana ;
D'Amico, Mauro ;
Granetto, Cristina ;
Cazzaniga, Marina ;
Boni, Luca ;
Fontanini, Gabriella ;
Falcone, Alfredo .
LANCET ONCOLOGY, 2015, 16 (13) :1306-1315
[22]   The Blood-Brain Barrier [J].
Daneman, Richard ;
Prat, Alexandre .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2015, 7 (01)
[23]   Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy [J].
Dor, Y ;
Djonov, V ;
Abramovitch, R ;
Itin, A ;
Fishman, GI ;
Carmeliet, P ;
Goelman, G ;
Keshet, E .
EMBO JOURNAL, 2002, 21 (08) :1939-1947
[24]   Antiangiogenic therapy: impact on invasion, disease progression, and metastasis [J].
Ebos, John M. L. ;
Kerbel, Robert S. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (04) :210-221
[25]   Neural guidance molecules regulate vascular remodeling and vessel navigation [J].
Eichmann, A ;
Makinen, T ;
Alitalo, K .
GENES & DEVELOPMENT, 2005, 19 (09) :1013-1021
[26]   Combined inhibition of VEGF- and PDGF-signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms [J].
Erber, R ;
Thurnher, A ;
Katsen, AD ;
Groth, G ;
Kerger, H ;
Hammes, HP ;
Menger, MD ;
Ullrich, A ;
Vajkoczy, P .
FASEB JOURNAL, 2003, 17 (15) :338-340
[27]   Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction -: The Doppler substudy of the reinfusion of enriched progenitor cells and infarct remodeling in acute myocardial infarction (REPAIR-AMI) trial [J].
Erbs, Sandra ;
Linke, Axel ;
Schaechinger, Volker ;
Assmus, Birgit ;
Thiele, Holger ;
Diederich, Klaus-Werner ;
Hoffmann, Christina ;
Dimmeler, Stefanie ;
Tonn, Torsten ;
Hambrecht, Rainer ;
Zeiher, Andreas M. ;
Schuler, Gerhard .
CIRCULATION, 2007, 116 (04) :366-374
[28]   Angiogenesis A Harmonized Target for Recovery After Stroke [J].
Ergul, Adviye ;
Alhusban, Ahmed ;
Fagan, Susan C. .
STROKE, 2012, 43 (08) :2270-2274
[29]   Netrin-4 Delays Colorectal Cancer Carcinomatosis by Inhibiting Tumor Angiogenesis [J].
Eveno, Clarisse ;
Broqueres-You, Dong ;
Feron, Jean-Guillaume ;
Rampanou, Aurore ;
Tijeras-Raballand, Annemilai ;
Ropert, Stanislas ;
Leconte, Laurence ;
Levy, Bernard I. ;
Pocard, Marc .
AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (04) :1861-1869
[30]  
Fala Loretta, 2015, Am Health Drug Benefits, V8, P49